Zymeworks, Inc. (ZYME)
25.15
-0.69
(-2.67%)
USD |
NASDAQ |
Nov 18, 12:31
Zymeworks Price to Book Value : 6.984 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 7.176 |
| November 16, 2026 | 7.345 |
| November 13, 2026 | 7.287 |
| November 12, 2026 | 7.351 |
| November 11, 2026 | 8.073 |
| November 10, 2026 | 8.736 |
| November 09, 2026 | 8.556 |
| November 06, 2026 | 8.228 |
| November 05, 2026 | 7.980 |
| November 04, 2026 | 8.592 |
| November 03, 2026 | 8.367 |
| November 02, 2026 | 8.050 |
| October 30, 2026 | 7.945 |
| October 29, 2026 | 7.973 |
| October 28, 2026 | 8.025 |
| October 27, 2026 | 8.012 |
| October 26, 2026 | 7.878 |
| October 23, 2026 | 7.837 |
| October 22, 2026 | 7.898 |
| October 21, 2026 | 7.807 |
| October 20, 2026 | 7.473 |
| October 19, 2026 | 7.092 |
| October 16, 2026 | 6.951 |
| October 15, 2026 | 7.151 |
| October 14, 2026 | 6.878 |
| Date | Value |
|---|---|
| October 13, 2026 | 6.962 |
| October 12, 2026 | 7.034 |
| October 09, 2026 | 7.162 |
| October 08, 2026 | 7.015 |
| October 07, 2026 | 7.367 |
| October 06, 2026 | 7.123 |
| October 05, 2026 | 7.278 |
| October 02, 2026 | 6.984 |
| October 01, 2026 | 7.209 |
| September 30, 2026 | 7.356 |
| September 29, 2026 | 24.35 |
| September 28, 2026 | 24.28 |
| September 25, 2026 | 23.75 |
| September 24, 2026 | 24.01 |
| September 23, 2026 | 24.62 |
| September 22, 2026 | 24.68 |
| September 21, 2026 | 24.01 |
| September 18, 2026 | 23.79 |
| September 17, 2026 | 24.61 |
| September 16, 2026 | 23.50 |
| September 15, 2026 | 23.33 |
| September 14, 2026 | 24.04 |
| September 11, 2026 | 23.50 |
| September 10, 2026 | 23.67 |
| September 09, 2026 | 24.31 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Faeth Therapeutics, Inc. | 1.420 |
| ACADIA Pharmaceuticals, Inc. | 2.267 |
| Alnylam Pharmaceuticals, Inc. | 5.661 |
| Anika Therapeutics, Inc. | 1.295 |
Price to Book Value Related Metrics
| PE Ratio | 48.16 |
| PS Ratio | 7.075 |
| Price | 25.15 |
| Earnings Yield | 2.08% |
| Market Cap | 1.804B |
| Operating PE Ratio | 42.62 |
| Normalized PE Ratio | 47.90 |